MDxHealth Q4 Preliminary Revenue Climbs; Initiates 2025 Revenue Outlook

(RTTNews) - MDxHealth SA (MDXH), a precision diagnostics company, on Monday reported preliminary fourth quarter revenue and issued revenue guidance for the full-year 2025.

For the fourth quarter, the company expects to record revenue of around $24.7 million, up 28 percent from last year. For the full-year 2024, the firm anticipates revenue of $90 million, up 28 percent from the previous year.

Looking ahead, Michael K. McGarrity, CEO of MDxHealth, said: "We are confident that the strength of our sales channel coupled with our expanded menu offering to our urology customer base will continue to drive sustainable growth."

For the full-year 2025, MDxHealth expects revenue of $108 million to $110 million, which represents year-over-year growth of 20 percent to 22 percent.

The company has also confirmed the view for its first-half adjusted EBITDA profitability.

The company will release its annual earnings report on February 26.

MDXH was up by 11.11 percent at $2.200 in the pre-market trade on the Nasdaq.